Compare CF Industries Holdings, Inc. (CF) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CF Industries Holdings, Inc. vs Citius Pharmaceuticals Inc — how do they compare? CF Industries Holdings, Inc. trades at $118.6 (market cap $18.58B), while Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M). The key difference: CF Industries Holdings, Inc. is far larger — about 1252.9× Citius Pharmaceuticals Inc's market cap, and CF Industries Holdings, Inc. pays a 1.98% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CF | CTXR | |
|---|---|---|
Market Cap | $18.58B | $14.83M |
Sector | Basic Materials | Health |
52-Week High | $137.55 | $1.82 |
52-Week Low | $76.08 | $0.53 |
Enterprise Value | $20.15B | $11.05M |
Dividend Yield | 1.98% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CF Industries stock trades at $120.92, up 3.42% today, with a bullish technical outlook and strong fundamentals. Recent earnings beats, a 20% dividend hike announced July 8, 2026, and robust profitability metrics like a 23.73% net margin support investor confidence. The stock is near consensus price targets, with moving averages signaling upward momentum.
The outlook is positive, driven by firm nitrogen demand and shareholder returns, but risks include input cost pressures and cyclical industry headwinds. Upside potential exists if earnings continue to exceed expectations, though overbought RSI levels suggest near-term consolidation may occur.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About CF Industries Holdings, Inc.
CF Industries is a leading producer and distributor of nitrogen fertilizers. The company operates seven nitrogen facilities in North America and holds joint venture interests in further production capacity in the United Kingdom and Trinidad and Tobago. CF makes nitrogen primarily using low-cost U.S. natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally.
Read more on CF →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
